0001665160-22-002912.txt : 20221114 0001665160-22-002912.hdr.sgml : 20221114 20221114154828 ACCESSION NUMBER: 0001665160-22-002912 CONFORMED SUBMISSION TYPE: C/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 20/20 GeneSystems, Inc. CENTRAL INDEX KEY: 0001139685 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 522272107 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C/A SEC ACT: 1933 Act SEC FILE NUMBER: 020-30706 FILM NUMBER: 221384580 BUSINESS ADDRESS: STREET 1: 9430 KEY WEST AVENUE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2404536339 MAIL ADDRESS: STREET 1: 15810 GAITHER ROAD, SUITE 235 CITY: GAITHERSBURG STATE: MD ZIP: 20877 FORMER COMPANY: FORMER CONFORMED NAME: 20/20 GENE SYSTEMS INC DATE OF NAME CHANGE: 20010502 C/A 1 primary_doc.xml C/A 0001139685 XXXXXXXX 020-30706 LIVE false false false true Issuer is extending campaign end date 20/20 GeneSystems, Inc. Corporation DE 08-07-2000 15810 GAITHER ROAD, SUITE 235 GAITHERSBURG MD 20877 https://2020gene.com/ N StartEngine Capital, LLC 0001665160 007-00007 Up to 9% percent We charge 3% commission paid in equity or securities at the same rate as this offering. Other Convertible Note 9995 N/A 9995.40 Y Other At issuer's discretion, with priority given to StartEngine Owners 4999995.00 12-15-2022 45.00 10272281.00 4677734.00 3354469.00 3468192.00 4215465.00 205071.00 0.00 103860.00 0.00 40247.00 9622332.00 2330528.00 4927374.00 1453354.00 0.00 0.00 2071777.00 -2021826.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY 20/20 GeneSystems, Inc. Jonathan Cohen CEO, President Jonathan Cohen CEO, President 11-14-2022 Anne Shiflett Director of Finance 11-14-2022 Richard Cohen Director 11-14-2022 John Rollins Director 11-14-2022 Michael A Ross Director 11-14-2022